EP3197275
4:3 NALTREXONE: 5-METHYL-2-FURALDEHYDE COCRYSTAL
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
24.9.2015EP published:
24.11.2021EP application number:
15844034.7
EPO information:
European Patent Register
Max expiry date:
23.9.2035
Title in English:
4:3 NALTREXONE: 5-METHYL-2-FURALDEHYDE COCRYSTALLanguage of the patent:
English
Timeline
Today
24.9.2015EP application
24.11.2021EP Publication
Owner
Name:
Pain Therapeutics, Inc.Address:
7801 N Capital of Texas Highway, Suite 260, Austin TX 78731, US
Inventor
Name:
BARBIER, RemiAddress:
Austin, TX 78746, US
Name:
FRIEDMANN, NadavAddress:
Georgetown, TX 78633, US
Name:
SRIRAMBHATLA, VijayAddress:
Edgbaston Birmingham B15 2DL, GB
Name:
WATT, StephenAddress:
East Lothian Scotland EH33 2QJ, GB
Name:
ZAMLOOT, MichaelAddress:
Austin, TX 78746, US
Priority
Number:
201462054515 PDate:
24.9.2014Country:
US
Number:
201562200309 PDate:
3.8.2015Country:
US
Classification
Categories:
A61K 9/70, A61K 31/341, A61K 31/4468, A61K 31/485, C07D 489/08